References in periodicals archive ?
These agents (factor VIII inhibitor bypassing agent or recombinant factor VIIa), in spite of the fact that they do not contain factor VIII are effective in these patients because they bypass the factor VIII deficiency by increasing the activity of other coagulation factors.
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.
(17.) Shander A, Goodnough LT, Rakto et al: Consensus recommendations for off lable use of Recombinant factor VIIA (Novoseven) therapy, P&T 2005; 30: 644-58.
LFB has been producing limited amounts of Factor VIIa in the milk of rabbits in France.
Recombinant factor VIIa and FFRck-fVIIa (XXV22W, 2.65 mg protein/mL) were kindly provided by Dr.
Funciona como receptor de procesos de inflamacion y apoptosis, pero tambien se considera el iniciador de la coagulacion al ser expuesto al plasma por una lesion vascular, y viene a desempenarse como cofactor de la accion del factor VIIa [13,14].
Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation.
(2-6) In life-threatening bleeding situations, even without pre-existing coagulopathies, recombinant factor VIIa (rFVIIa) seems to be a possible choice for treatment.